Corindus Vascular Robotics
Corindus Vascular Robotics was founded in 2002 by Rafael Beyar, an interventional cardiologist, and Tal Wenderow. Its goal is to use remote control and robotics to move coronary guidewires and balloon/stent catheters.
Corindus, Inc. is based in Waltham, Massachusetts. The company's FDA-cleared CorPath® System is the first medical device that allows interventional cardiologists to manipulate guidewires and balloon/stents from an interventional cockpit.
The company went public in August 2014 and currently trades on the New York Stock Exchange with the ticker symbol CVRS.
In August 2019 Siemens Healthineers announced its intention to acquire Corindus Vascular Robotics for 1.1 billion US-Dollar.
